
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases
Hongbin Liu, Xiaoyan Zhan, Guang Xu, et al.
Pharmacological Research (2020) Vol. 164, pp. 105384-105384
Closed Access | Times Cited: 66
Hongbin Liu, Xiaoyan Zhan, Guang Xu, et al.
Pharmacological Research (2020) Vol. 164, pp. 105384-105384
Closed Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 80
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 80
Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction
Qiang Li, Hui Feng, Hongbo Wang, et al.
EMBO Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 73
Qiang Li, Hui Feng, Hongbo Wang, et al.
EMBO Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 73
Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway
Yali Zhao, Chongyu Shao, Huifen Zhou, et al.
Phytomedicine (2023) Vol. 119, pp. 155002-155002
Closed Access | Times Cited: 33
Yali Zhao, Chongyu Shao, Huifen Zhou, et al.
Phytomedicine (2023) Vol. 119, pp. 155002-155002
Closed Access | Times Cited: 33
Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mTOR signaling pathway
Jie-ru Yu, Yuyue Liu, Yangyang Gao, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117791-117791
Open Access | Times Cited: 9
Jie-ru Yu, Yuyue Liu, Yangyang Gao, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117791-117791
Open Access | Times Cited: 9
Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway
Yanfang Deng, Qianqian Xu, Tianqi Chen, et al.
Phytomedicine (2022) Vol. 104, pp. 154241-154241
Closed Access | Times Cited: 34
Yanfang Deng, Qianqian Xu, Tianqi Chen, et al.
Phytomedicine (2022) Vol. 104, pp. 154241-154241
Closed Access | Times Cited: 34
Effects of NLRP3 Inflammasome Mediated Pyroptosis on Cardiovascular Diseases and Intervention Mechanism of Chinese Medicine
Yi Zhong, Xinyue Li, Tian-jun Liang, et al.
Chinese Journal of Integrative Medicine (2024) Vol. 30, Iss. 5, pp. 468-479
Closed Access | Times Cited: 6
Yi Zhong, Xinyue Li, Tian-jun Liang, et al.
Chinese Journal of Integrative Medicine (2024) Vol. 30, Iss. 5, pp. 468-479
Closed Access | Times Cited: 6
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Nadire Özenver, Thomas Efferth
Pharmacological Research (2021) Vol. 170, pp. 105710-105710
Closed Access | Times Cited: 33
Nadire Özenver, Thomas Efferth
Pharmacological Research (2021) Vol. 170, pp. 105710-105710
Closed Access | Times Cited: 33
Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
Jia Zhao, Hongbin Liu, Zhixian Hong, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 13
Jia Zhao, Hongbin Liu, Zhixian Hong, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 13
NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
Zhilei Wang, Guang Xu, Zhiyong Li, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 409-422
Open Access | Times Cited: 19
Zhilei Wang, Guang Xu, Zhiyong Li, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 409-422
Open Access | Times Cited: 19
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Rui Qiang, Yanbo Li, Xin-can Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Rui Qiang, Yanbo Li, Xin-can Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Cryptotanshinone regulates gut microbiota and PI3K-AKT pathway in rats to alleviate CUMS induced depressive symptoms
Li-hua Bian, Siqi Wang, Wenjing Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115921-115921
Open Access | Times Cited: 12
Li-hua Bian, Siqi Wang, Wenjing Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115921-115921
Open Access | Times Cited: 12
Abietane diterpenoids from Orthosiphon wulfenioides with NLRP3 inflammasome inhibitory activity
Wen‐Chao Tu, Ying-Xin Zhao, Changlin Yang, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106534-106534
Closed Access | Times Cited: 11
Wen‐Chao Tu, Ying-Xin Zhao, Changlin Yang, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106534-106534
Closed Access | Times Cited: 11
Parthenolide targets NLRP3 to treat inflammasome-related diseases
Liu Liu, Linxiang Feng, Jiahui Gao, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110229-110229
Open Access | Times Cited: 11
Liu Liu, Linxiang Feng, Jiahui Gao, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110229-110229
Open Access | Times Cited: 11
Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications
Ziyao Zheng, Liyuan Ke, Silin Ye, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6031-6060
Open Access | Times Cited: 4
Ziyao Zheng, Liyuan Ke, Silin Ye, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6031-6060
Open Access | Times Cited: 4
Exploring the health benefits of food bioactive compounds from a perspective of NLRP3 inflammasome activation: an insight review
Yabo Li, Xinyi Wang, Ying Ren, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-26
Closed Access
Yabo Li, Xinyi Wang, Ying Ren, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-26
Closed Access
Identification of a Novel NPC1L1 Inhibitor from Danshen and Its Role in Nonalcoholic Fatty Liver Disease
Donghai Xia, Xuan Jiang, Xiaomin Xie, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2793-2793
Open Access
Donghai Xia, Xuan Jiang, Xiaomin Xie, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2793-2793
Open Access
Flavonoids and phenolic acids from Lablab Flos Alba and their anti-inflammatory activity via NLRP3 inflammasome
Huimin Li, Zhongwei Shi, Wei Zhang, et al.
Fitoterapia (2025) Vol. 183, pp. 106533-106533
Closed Access
Huimin Li, Zhongwei Shi, Wei Zhang, et al.
Fitoterapia (2025) Vol. 183, pp. 106533-106533
Closed Access
Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis
Lutong Ren, Qiang Li, Hui Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3295-3312
Closed Access | Times Cited: 17
Lutong Ren, Qiang Li, Hui Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3295-3312
Closed Access | Times Cited: 17
Phytoestrogens, novel dietary supplements for breast cancer
Shuo Huang, Baowen Qi, Ling Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114341-114341
Open Access | Times Cited: 10
Shuo Huang, Baowen Qi, Ling Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114341-114341
Open Access | Times Cited: 10
Diterpenoids with a novel 6/5-5 spiro tricyclic skeleton from Orthosiphon wulfenioides and their NLRP3 inflammasome inhibitory activity
Wen‐Chao Tu, Xing‐Jie Zhang, Ying-Xin Zhao, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 12, pp. 2898-2906
Closed Access | Times Cited: 10
Wen‐Chao Tu, Xing‐Jie Zhang, Ying-Xin Zhao, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 12, pp. 2898-2906
Closed Access | Times Cited: 10
Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapy
Wendan Zhang, Honghong Jiang, Peng-li Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Wendan Zhang, Honghong Jiang, Peng-li Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases
Zhaofang Bai, Yan Wang, Shuyi Bian, et al.
Phytomedicine (2023) Vol. 122, pp. 155159-155159
Closed Access | Times Cited: 9
Zhaofang Bai, Yan Wang, Shuyi Bian, et al.
Phytomedicine (2023) Vol. 122, pp. 155159-155159
Closed Access | Times Cited: 9
The “Top 50 High Impact Researches of Traditional Medicine” published in 2021
Xiao Li, Dong Xu, Jian‐Feng Tu, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 4, pp. 232-243
Open Access | Times Cited: 9
Xiao Li, Dong Xu, Jian‐Feng Tu, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 4, pp. 232-243
Open Access | Times Cited: 9
Dimethyl fumarate covalently modifies Cys673 of NLRP3 to exert anti-inflammatory effects
Huiting Hu, Yuqian Cai, Yuanfang Shi, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109544-109544
Open Access | Times Cited: 3
Huiting Hu, Yuqian Cai, Yuanfang Shi, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109544-109544
Open Access | Times Cited: 3
Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes
Yulu Yan, Xiqi Ye, Huang Chunqing, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 9, pp. 1212-1224
Closed Access | Times Cited: 3
Yulu Yan, Xiqi Ye, Huang Chunqing, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 9, pp. 1212-1224
Closed Access | Times Cited: 3